Feedback Share Discussion Threads

[ged5] 29/8/2019 14:11

So as expected all resolutions passed.

Now let's get some sales starting next week at the Expo.

[ged5] 29/8/2019 13:38

Yep! received the same 27 mins ago.

[ducatiman] 29/8/2019 13:27

As a subscriber to our news updates, we are pleased to let you know that we will be launching our innovative new product, Bleepa™, at the prestigious NHS Health and Care Innovation Expo, Manchester on 4th and 5th September.

We have developed Bleepa™ as a novel messaging app to allow clinicians to share, review and discuss clinical grade medical images. We, at Feedback Medical, believe it will transform the ability to securely read and discuss patient scans and treatments. This gives the potential to shorten A&E waiting times, improve patient management and accelerate discharge, as well as reducing the risks associated with clinical communications occurring outside of hospital systems.

We will be demonstrating the power of Bleepa™ at Stand 29 at Expo and we look forward to meeting up if you are attending.

Regular updates from the event will be posted at


Best wishes

Dr Tom Oakley
CEO, Feedback Medical

@bleepame @bleepame
www.bleepa.com www.bleepa.com
[e-mail] [e-mail]
Bleepa™ is a product by Feedback Medical Ltd. Feedback Medical Ltd is a company registered in England and Wales - Registered Number: 04025026 - Registered Office: Grange Park, Broadway, Bourn, Cambridgeshire, CB23 2TA, UK.
Copyright © 2019 Feedback Medical Ltd, All rights reserved.

We do not pass any contact details to third parties. We have your contact details on file because you are registered as a current TexRAD or Cadran customer; as a software or PACS user, technical or financial contact, subscribed on our website, or because you have shown specific interest in purchasing our software within recent months.

Our mailing address is:
Grange Park, Broadway, Bourn, Cambridge. CB23 2TA United Kingdom

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

[botak54] 29/8/2019 10:28

Agree Ged
A significant Heavy Weight Investor throwing £2.8m for 2M shares would be transformational in terms of confidence]and strategic play
Cmon all you Ultra High Net Worth players join the party




Please !

[ged5] 29/8/2019 10:08

Yes, we just want a well managed company with plenty of sales. A cornerstone investor is needed. Perhaps we'll find out we have one.

Anybody going to the meeting at lunchtime?

[bobd29] 29/8/2019 09:42

Had to happen Ged5, a good move for FDBK imo. Not interested in the politics but the combination of TO and RS at the helm should benefit Bleepa sales and TexRAD adoption. Just now need to see what effect any overhang has tomorrow onwards, perhaps iis will take up most that are on offer? Interesting times ahead.

[ged5] 29/8/2019 09:11

Dr Alastair Riddell's bullish interviews was one of the reasons I bought in here after the last placing. He could certainly deliver in an interview.

He was also the reason for great disappointment when his words didn't materialise into actions. He most certainly couldn't deliver action.

Probably his greatest act is finding and appointing Dr Tom Oakley.

Time to move on so thank you Alastair, enjoy your retirement.

Welcome to your new position Professor Rory Shaw. Perhaps we'll see a change in shareholder relationships as well as an exciting change in direction.

I was just reading about Professor Shaw yesterday after seeing the short video and thought what great credentials he has to be on the board. His experience and connections will be invaluable in this next stage of the company's transition.

These two paragraphs say it all:-

"Professor Rory Shaw has extensive managerial and overseas trade experience as well as a strong academic and clinical background. As Medical Director of Feedback Medical, over the last year he has contributed to the development of the Company's new strategy and to building relationships with the UK medical community.

Professor Shaw was previously the Medical Director of Healthcare UK within the Department of International Trade. Over the previous 15 years, he has been Medical Director of three NHS Trusts; North West London Hospitals NHS Trust, the Royal Berkshire NHS Foundation Trust and the Hammersmith Hospital NHS Trust. In 2001, he was appointed by the then Minister of Health as the first Chairman of the National Patient Safety Agency and was also a non-executive director of the NHS Litigation Authority. Professor Shaw's clinical specialty is respiratory and general medicine. He has been published extensively in academic journals and was also a professor of respiratory medicine at Imperial College School of Medicine."

[hazl] 29/8/2019 07:59

Indeed zooskeeper.

6 days to go.

[hazl] 29/8/2019 07:38

'Non-executive Chairman, Dr Alastair Riddell, has informed the Company that he intends to retire at the Company's next annual general meeting. At such time, it is intended that Professor Rory Shaw will be appointed non-executive Chairman of Feedback.



Professor Rory Shaw will step down immediately from his post as Medical Director of Feedback Medical Limited, the Company's operating subsidiary, which he has held since June 2018. The functions of the post will be covered internally.

Professor Rory Shaw has extensive managerial and overseas trade experience as well as a strong academic and clinical background. As Medical Director of Feedback Medical, over the last year he has contributed to the development of the Company's new strategy and to building relationships with the UK medical community.

Professor Shaw was previously the Medical Director of Healthcare UK within the Department of International Trade. Over the previous 15 years, he has been Medical Director of three NHS Trusts; North West London Hospitals NHS Trust, the Royal Berkshire NHS Foundation Trust and the Hammersmith Hospital NHS Trust. In 2001, he was appointed by the then Minister of Health as the first Chairman of the National Patient Safety Agency and was also a non-executive director of the NHS Litigation Authority. Professor Shaw's clinical specialty is respiratory and general medicine. He has been published extensively in academic journals and was also a professor of respiratory medicine at Imperial College School of Medicine.'

What a wealth of experience.
And thanks to Dr.Riddell for past endeavours.

[zooskeeper] 29/8/2019 07:28

Less than a week to launch now. Hoping we can continue the slow climb

[hazl] 28/8/2019 16:07

Not that many blue today...23%
Well done FDBK.

[davydoo] 28/8/2019 15:14

Love that video. It’s such a simple concept to understand and see the benefit of. Let’s hope the expo attendees hope so too, early adopters will be key

[newtothisgame3] 28/8/2019 14:03

#FDBK @BleepaMe LIVE INTERVIEW 1 MINUTE AGO Bleepa

[hazl] 28/8/2019 13:23

2 good shares beginning with F!

[newtothisgame3] 28/8/2019 12:22

Bleepa
‏

@BleepaMe
1h1 hour ago
More
Only 1 week to go until @ExpoNHS ! woohoo 🎉🎉🎉

The teams at @FBKmed and @FutureProcessin are working round the clock to get Bleepa nicely polished, ready for launch

Visit us at Stand 29 to see the Future of NHS Communication

[hazl] 28/8/2019 08:29

7 days to go!

[ducatiman] 27/8/2019 18:22

NHS pension fund LR2?

[lr2] 27/8/2019 16:47

Trade No. 47 was interesting.

27-Aug-19 16:21:43 1.4p 2,000,000 Buy*

[botak54] 27/8/2019 15:50

Appreciate ur response hazl, TBO Personally I have no expectations on share price level , With 530 million shares in issue 166M of those Have Green light to hit the market this Friday ( the New Ordinary Shares are expected to be admitted to on AIM on 30 August 2019.) With a balanced volume today so far and we stay in the 1.30,s
There is potential for a quagmire to hold back any share price progress with the 10% ers dominating trading, On the flip side Bleepa could well morph into multi app ,multi adoption piece of kit that exceeds all our expectations regards ROI, Will that be allowed to happen ?, TO & Co need to prove to the market they can generate revenue PDQ for any breakout to be sustained , Otherwise imo it will be akin to the final scenes from Titanic

[hazl] 27/8/2019 15:37

I am sure that we will get some sort of communication from Feedback
about commercial interest when the time is right.

[hazl] 27/8/2019 15:20

Its a good question Botak AND I would say that judging by other similar things I have seen,interest gradually accumulates as the time nears,depending on the marketing skills of the company concerned.
We all presumably have faith in the products or we wouldn't be here so a lot depends on the ability of Feedback to promote their Bleepa product.

I think we will soon know as literally we will get feedback as visibility is achieved.

[botak54] 27/8/2019 15:08

What exactly do you expect from the launch hazl ? What are your expectations on the Day ?, Inline with the running countdown

[ducatiman] 27/8/2019 15:04

Yes, shame the rise couldn't be sustained however volume is good and we are holding above placing price, for now anyway.

[hazl] 27/8/2019 14:43

Well I popped out for a minute to see our gains eroded!

Won't be long till the launch folks!

[petekand] 27/8/2019 13:22

I didn't deem it appropriate to comment here whilst I was enjoying my long summer break with family. But I am back now although will be needing a few days to deal with other matters.